Pill-Based Obesity Device From Gelesis Gets Financing
This article was originally published in The Pink Sheet Daily
Executive Summary
Startup Gelesis Inc. announced a $12 million funding round to support an FDA study for its Gelesis 100 “smart pill” as a tool to induce feelings of hunger and satiety.